MCMehmet Cindoruk

Mehmet Cindoruk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mehmet Cindoruk has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Nationwide Cross-Sectional Study on Endoscopy-Related Musculoskeletal Injuries: The Hidden Occupational Burden of Gastroenterologists in Türkiye

    by Halit Kandemir, Guner Kilic, Ali Karataş, Kenan Moral, Enes Cömert, Beril Demir, Derya Kirman, Murat Kekilli, Mehmet Cindoruk, Tarkan Karakan

    Background/Objectives: Endoscopic procedures-related musculoskeletal injuries (ERMI) are a major problem in gastroenterologists. ERMI arises from increased workload, extended times of advanced endoscopic procedures, and repetitive overuse. There has been no study for ERMI among gastroenterologist in Türkiye. This study aimed to assess the frequency, causes, and risk factors associated with ERMI among gastroenterologists in Türkiye. Methods: A 26-item electronic survey was sent to 1,100 Turkish Gastroenterology Association physician members and to 253 gastroenterology fellows still in training. Demographic characteristics, prevalence of ERMI, workload parameters and possible risk factors were evaluated by univariate and multivariate analyses Results: The survey was completed by 132 gastroenterologists, 78% of respondent were male, with a mean professional experience of 11 years. Overall, 72% reported experiencing at least one ERMI during their career, and 63.2% reported injuries involving multiple joints. The most commonly affected areas were the neck, left thumb and right wrist. Significant differences in ERMI were observed based on gender, affiliated institution, and total weekly number of procedures. Regarding injury severity, sex and glove size were significant factors. In logistic regression analysis, female sex increased the risk of ERMI by 5.6 times, and performing ERCP procedures increased the risk by 2.6 times. Conclusions: ERMI is highly prevalent among gastroenterologists in Turkey and represents a significant occupational health problem with implications on work loss. Preventive strategies such as reducing the volume of procedures, increasing the frequency of breaks, and making ergonomic adjustments in procedure rooms are necessary to reduce the risk of ERMI.

  • Open Access

    Intestinal Ultrasound: Advancing Towards Broader Adoption—Insights from a National Survey in Turkey

    by Gülden Bilican, Tarkan Karakan, Ödül Eğritaş Gürkan, Mehmet Cindoruk, Charlotte Hedin, Haider Sabhan, Ayşe Can, Stephan L. Haas

    Objective: Intestinal ultrasound (IUS) is increasingly valued as a noninvasive tool for inflammatory bowel disease (IBD) management, offering real-time, radiation-free assessment of bowel wall thickness, vascularity, and complications. While IUS is widely adopted in Europe, data on its use in Turkey is scarce. This study aims to address this gap. Methods: A nationwide, cross-sectional survey was conducted targeting 817 adult and 150 pediatric gastroenterologists in Turkey. The survey included 26 structured questions on demographics, familiarity with and use of IUS, and barriers to implementation. Results: A total of 191 gastroenterologists participated in this survey, with 56% being adult gastroenterologists (n = 107) and 44% pediatric gastroenterologists (n = 84). Regarding whether they participated in IUS training, 73% (n = 140) of the 191 respondents stated they had not received training. There were notable differences in how IUS was utilized among gastroenterologists: 29% (n = 31) of adult gastroenterologists performed IUS independently, compared to just 2% (n = 2) of pediatric gastroenterologists (p < 0.001). In total, 63% (n = 67) of adult gastroenterologists and 46% (n = 39) of pediatric gastroenterologists reported not using IUS. Altogether, 94% (n = 179) emphasized the necessity of educational opportunities, and 86% (n = 165) favored national guidelines. Conclusions: Our findings reveal that the current application of IUS in Turkey fails to correspond with its expected advantages in managing IBD. Limited educational opportunities are a major challenge, emphasizing the necessity for coordinated educational programs and national guidelines. The expanded adoption of the IUS might significantly improve Turkey’s management of IBD. What is known: Intestinal ultrasound (IUS) is a non-invasive, cost-effective, and reliable imaging method increasingly recognized for its utility in diagnosing and monitoring inflammatory bowel disease (IBD). What is new: This is the first national survey assessing the awareness, usage patterns, and barriers to the adoption of IUS among gastroenterologists in Turkey. The study highlights significant gaps in training opportunities while also identifying strategies to promote IUS integration into routine clinical practice. The findings may encourage similar efforts in other regions where IUS remains underutilized, ultimately improving IBD management and patient outcomes globally.


  • Open Access

    Evaluation of Tryptophan and Its Metabolites in Predicting Disease Activation in Inflammatory Bowel Disease

    by Ali Karataş, Tarkan Karakan, Nergiz Ekmen, Yasemin Ünsal, Gülsüm Feyza Türkeş, Özlem Gülbahar, Mehmet Cindoruk, Mustafa Ergin, Güner Kılıç, Mehmet İbiş, et al.

    Background and Aim: Inflammatory bowel disease (IBD), which comprises ulcerative colitis (UC) and Crohn’s disease (CD), is characterized by chronic inflammation and fluctuating disease activity. This study aimed to evaluate serum tryptophan (TRP) and its metabolites as potential biomarkers for predicting disease activation in comparison to fecal calprotectin (FC). Methods: This prospective study included 115 patients (77 with UC and 38 with CD). Disease activity was assessed based on clinical and endoscopic findings. Serum TRP levels and their metabolites were measured using liquid chromatography–tandem mass spectrometry (LC-MS/MS), whereas FC levels were analyzed using an enzyme-linked immunosorbent assay (ELISA). Results: Serum TRP levels ≤ 11,328.41 ng/mL predicted disease activation with 72.1% sensitivity and 62.7% specificity, whereas FC levels ≥ 89.60 µg/g showed 84.2% sensitivity and 67.6% specificity. The TRP-to-C-reactive protein (CRP) ratio (TRP/CRP) demonstrated superior diagnostic accuracy, with an area under the curve (AUC) of 0.847. Conclusions: The TRP/CRP ratio is a novel and comprehensive approach for predicting disease activation in IBD patients. Although FC remains the gold standard, TRP and its metabolites provide valuable complementary insights. Further research is required to validate these findings in larger cohorts.


  • Open Access

    A Comparison of Pancreatic Pseudocysts with True Pancreatic Cysts According to Endosonographic Criteria(A Six-Year Retrospective Analysis)

    by Memduh Şahi̇n, Tarkan Karakan, Mehmet Ci̇ndoruk

    Background and aims: During the past years, endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) has become an important tool in cyst therapy and tissue sampling. In this retrospective analysis, the primary objective was to determine the efficacy of EUS guided FNA for diagnosis of pancreatic pseudocysts (PP) and true cysts. The secondary aim was to evaluate the size and location of the cysts. Method: Eighty-three patients with pancreatic cysts and pseudocysts were retrospectively identified from the database of Gazi University Department of Gastroenterology. Size of the cysts and available data on fine needle aspiration and surgical aspiration were also recorded. Results: According to EUS criteria, 48 patients (57.8%), 24 female and 24 male subjects with PP and 35 (42.2%) patients (24 female and 11 male) with cystic lesions (totally 83 patients, 48 female and 35 male) were enrolled in the study The size of the cysts in the pseudocyst group was significantly greater than that of the simple cysts. There was no difference between the two groups in terms of patients age.. There was also no difference between the two study groups in terms of location (p= 0.404). The most common location for both cysts was the head of the pancreas. Normal cytology was the most common finding among cytological results of fine needle aspiration in the both groups. Bacterial growth was detected in one sample and fungal culture was positive in another in the PP group . One of the samples showed atypical cells and another demonstrated mucinous cells in the same subgroup. There were four cases with mucinous cystic neoplasm and one case with cystadenocarcinoma in the true cyst group. Conclusion: Cysts of the pancreas have some characteristic properties that can be differentiated with EUS guidance. Amaç :Son yıllarda , Endoskopik Ultrason (EUS) eşliğinde yapilan ince iğne aspirasyon işlemi (FNA) kist tedavisi ve kistin içeriğinden örnek alımında önemli yer tutmaya başlamıştır. Yaptığımız bu retrospektif analizde EUS yolu ile ince iğne biyopsisinin pankreatik kist ve psödokistlerdeki tanısal etkinliği incelenmiştir. İkincil amaç olarak psödokistlerin ve gerçek kistlerin boyut ve lokalizasyon olarak farklılığı analiz edilmiştir. Gereç ve Yöntemler:Retrospektif olarak elde edilen ve psödokist ile gerçek pankreatik kist tanısı alan 83 hastanın bilgileri Gazi Üniversitesi Gastroenteroloji Bölümü veritabanından elde edilmiştir.Bu veriler ile kist boyutları ve sonradan elde edilen ince iğne aspirasyon ve cerrahi patolojik sonuçlar değerlendirilip analiz edilmiştir . Bulgular:Değerlendirilen toplam vaka sayısı 83 (48 kadın ve 35 erkek) olup yapılan karşılaştırmada 24 kadın ve 24 erkek hastadan oluşan 48 (%57,8) hasta pankreatik psödokist olarak ele alınmıştır. 35 (%42,2) (25 kadın ve 11 erkek) hastadan oluşan diğer grup ise gerçek kist tanımlaması ile endosonografik olarak değerlendirilmiştir. İstatistiksel olarak psödokistlerin endosonografik olarak boyutlarının daha geniş olduğu tespit edilmiştir. Yaş ve lokalizasyon (p=0.404) açısından iki grup arasında isatistiksel fark bulunamamıştır. Kistler her iki grupta da sıklıkla pankreasın baş kesiminde görüntülenmiştir. Tüm kist türleri patolojik sonuçlarına gore analiz edimiş olup her iki gruptaki dominant sonuçlar normal sitolojik veriler ile uyumlu idi.PP grubunda 1 vakada bakteriel başka bir vakada fungal kültür pozitif olarak tesbit edilmiştir. PP grubunda 1 vakada atipik hücreler ve 1 vakada müsinöz hücreler tespit edilmiştir. Gerçek kist grubunda 4 (11.4%) vakada müsinöz sitoloji bulunmuş olup bir vaka daha sonra cerrahi olarak kistadenokarsinom tanısı almıştır. Sonuç: Pankreatik kistler EUS ile ayrım yapılabilecek bir takım karakteristik özellikler taşımaktadır.

  • Electronic Clinical Challenges and Images in GI

    by Tarkan Karakan, Mehmet Cindoruk

  • Open Access

    Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

    by Mehmet Cindoruk, Mustafa Kerem, Tarkan Karakan, Bulent Salman, Okan Akin, Murat Alper, Ozlem Erdem, Selahattin Ünal

    Background: Peroxisome proliferators-activated receptor alpha (PPARα) activation modulates cholesterol metabolism and suppresses bile acid synthesis. This study aims to evaluate the effect of short-term administration of fenofibrate, a PPARα agonist, on proinflammatory cytokines, apoptosis, and hepatocellular damage in cholestasis. Methods: Forty male Wistar rats were randomly divided into four groups: I = sham operated, II = bile duct ligation (BDL), III = BDL + vehicle (gum Arabic), IV = BDL + fenofibrate (100 mg/kg/day). All rats were sacrificed on 7th day after obtaining blood samples and liver tissue. Total bilirubin, aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP), gamma-glutamyl transferase, (GGT), tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1 β), and total bile acid (TBA) in serum, and liver damage scores; portal inflammation, necrosis, bile duct number, in liver tissue were evaluated. Apoptosis in liver was also assessed by immunohistochemical staining. Results: Fenofibrate administration significantly reduced serum total bilirubin, AST, ALT, ALP, and GGT, TNF-α, IL-1 β levels, and TBA (P < 0.01). Hepatic portal inflammation, hepatic necrosis, number of the bile ducts and apoptosis in rats with BDL were more prominent than the sham-operated animals (P < 0.01). PPARα induction improved all histopathologic parameters (P < 0.01), except for the number of the bile duct, which was markedly increased by fenofibrate therapy (P < 0.01). Conclusion: Short-term administration of fenofibrate to the BDL rats exerts beneficial effects on hepatocellular damage and apoptosis.


  • Open Access

    The rare presentations of a large polyp and an esophageal carcinoma in heterotropic gastric mucosa: a case series

    by Hakan Alagozlu, Meltem Ergun, Mehmet Cindoruk, Selahattin Unal, Sukru Dumlu, Aylar Poyraz, Ayse Dursun

    Heterotopic gastric mucosa (HGM) is commonly seen in the upper esophagus during endoscopyand is generally considered a benign disease. A hyperplastic polyp and an adenocarcinoma arising in heterotopic gastric mucosa are quite rare occurences.


    • 1 December 2006
      • Vol. 17  (4) , 294-7

    Management of cervical esophageal strictures with self-expanding metalic stents.

    by Mehmet Cindoruk, Tarkan Karakan

    Esophageal strictures due to malignant diseases are treated with self-expanding metalicic stents. However, experience is limited with these metalic stents in the cervical esophagus. Due to technical difficulties and procedure-related complications, the cervical esophagus has been assigned as a risky area for stenting procedures. Another encountered problem is patient discomfort after the procedure. In this case report, we present three patients with cervical esophageal strictures who were successfully treated with self-expandable metalic stents. Two of these patients had inoperable esophageal carcinoma and the third had benign stenosis due to radiotherapy of larynx carcinoma. The two patients with malignant disease survived four and six months, respectively, after the procedure. The last patient with benign disease is still alive and has been without dysphagia symptom for six months.


  • Open Access

    Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy

    by Z Simsek, O Ekinci, M Cindoruk, T Karakan, B Degertekin, G Akyol, S Unal

    Background: Cytoplasmic inclusion bodies within hepatocytes may have different etiologies, including the Endoplasmic Reticulum Storage Diseases (ERSDs). ERSD is a pathological condition characterized by abnormal accumulation of proteins destined for secretion in the endoplasmic reticulum of hepatocytes; it may be congenital (primary) or acquired (secondary). Fibrinogen storage disease is a form of ERSD. Case Presentation: We present a case of fibrinogen storage disease secondary to estrogen replacement therapy. Its causal relationship to the drug is shown by histological, immunohistochemical and ultrastructural studies of paired liver biopsies obtained during and after the drug therapy. Conclusion: The liver biopsies of patients with idiopathic liver enzyme abnormalities should be carefully evaluated for cytoplasmic inclusion bodies and, although rare, fibrinogen deposits.